Every Second Counts
1
Infusing clinical and financial liquidity so that complex therapies can be immediately accessible by the largest number of patients
2
Enabling a team of world-class treatment centers to deliver breakthroughs faster and smarter
3
Creating new pathways for translational research and the next breakthroughs
Enabling The New Age of Breakthrough Innovation
Payers are not prepared for the cost and uncertainty underlying innovative new treatments. The Breakthrough Exchange establishes a new capital source to provide immediate liquidity to the high cost therapy markets, ensuring patients receive potentially curative treatments now.
There is a new wave of extraordinary treatments hitting the market. Many have the potential to become game changers but are going to cost between $500 thousand to more than $1MM per therapy. In addition to these drugs, a large portion of the cost is tied up in the services provided by the clinic, given the high complexity of administering the therapies.
Hospitals and large insurers are observing a faster than expected movement of many of these therapies to first-line, yet have no solution for how to finance these drugs and supporting services. This has created a significant backlog of patients in dire need at the nation’s elite treatment centers.
Current drug spending is out of control — especially with the increasingly rapid pace of new, breakthrough treatments
17
There are currently 17 gene and cell therapies approved
1000+
More than 1000 novel cell, gene and regenerative medicine trials are in development for a variety of diseases and conditions
$98B
Global cell therapy, gene therapy and Immuno-Oncology sales are projected to reach approximately $98 billion by 2024
